期刊文献+

叶酸干预高血压前期研究进展 被引量:3

原文传递
导出
摘要 高血压前期是指正常血压到确诊高血压之间的过渡阶段,血浆同型半胱氨酸(Hcy)升高是高血压及心血管病的独立危险因素,我国居民血浆Hcy升高与叶酸缺乏发生率较高,高Hcy血症致心血管病的病理机制涉及多个环节,叶酸通过降低血浆Hcy、抗氧化应激、对一氧化氮酶的作用等多个途径,改善血管内皮结构和功能,从而降低高血压的发生风险。
作者 卢跃棣 王文
出处 《江苏医药》 CAS 北大核心 2013年第12期1455-1457,共3页 Jiangsu Medical Journal
  • 相关文献

参考文献15

  • 1中国高血压防治指南修订委员会,中国高皿压防治指南2010[J].中华高电压杂志.2011,19(8):701-743.
  • 2Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detee tion, evaluation and treatment of high blood pressure:the JNC 7 report[J]. JAMA,2003,289(19):2560-2572.
  • 3Ozkan Y,Ozkan E, Simsek B. Plasma total homoeysteine and eysteine levels as cardiovascular risk factors in coronary heart disease[J], lnt J Cardiol, 2002,82 (3) : 269-277.
  • 4何广彦.同型半胱氨酸与高血压前期的关系[J].温州医学院学报,2011,41(6):567-568. 被引量:5
  • 5Li Z, Sun L, Zhang H, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetefrahydrofolate reductase gene C677T polymor phism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China [J]. Stroke, 2003,34 (9) :2085-2090.
  • 6Zhang W, Sun K,Chen J, et al. High plasma homoeysteine levels contribute to the risk of stroke recurrence and all cause mortality in a large prospective stroke population[J]. Clin gel (I.ond) ,2009,118(3) :187-194.
  • 7Sun Y,Chien KL,Hsu HC,et al. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12 year prospective cohort stndy[J ]. Circ J,2009,73 (8)11423-1430.
  • 8陈光亮,霍勇,李建平,刘力生,徐希平.复方I类新药依那普利叶酸片的创新思路[J].中国新药杂志,2009,18(17):1590-1593. 被引量:29
  • 9Yang Q, Botto LD, Eriekson JD, et al. Improvement in stroke mortality in Canada and the United States, 1990 to 2002[J]. Circulation, 2006,113(10): 1335-1343.
  • 10汪国海,霍勇,王梦德,邢厚恂,刘平,戴成祥,徐希平.中国六城市轻中度高血压患者血清叶酸水平的调查[J].卫生研究,2007,36(3):305-307. 被引量:30

二级参考文献38

  • 1张树琛,鲁炳怀,朱凤霞.原发性高血压患者血浆同型半胱氨酸水平的研究[J].实用医技杂志,2008,15(25):3353-3354. 被引量:8
  • 2饶明俐.《中国脑血管病防治指南》摘要(一)[J].中风与神经疾病杂志,2005,22(5):388-393. 被引量:211
  • 3Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 4WHO. CVD-Risk Management Package for low- and medium-resource settings[S]. 2002.
  • 5MANCIA G, DE BACKER G, DOMINICZAK A,et al. 2007 Guidelines for the management of arterial hypertension:the task force for tile management of arterial hypertension of the European Society of Hypertension(ESH) and the European Society of Cardiology ( ESC ) [ J ]. Hypertension, 2007,25 ( 6 ) : 1105 - 1187.
  • 6FDA. 21CFR300.50 Subpart B- combination drugs. Fixed-combination prescription drugs for humans[S].
  • 7EMEA. Note for guidance on fixed combination medicinal products[S]. London, 1996.
  • 8GRAHAM IM,DALY I,E,REFSUM HM,et al. Plasma homocysteine as a risk faclor for vascular disease. The European Concerted Action Project[J]. JAMA,1997,277(22) :1775 - 1781.
  • 9KJELDSEN SE, JULIUS S, HEDNER T, et al. Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials[ J]. Blood Pressure,2001,10(4) :190 - 192.
  • 10WOLF-MAIER K,COOPER RS, BANEGAS JR,et al. Hypertension prevalence and blood pressure levels in 6 European coun tries, Canada, and the United States [ J ]. JAMA. 2003,289 ( 18 ) 2363 - 2369.

共引文献290

同被引文献29

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部